Biovencer Healthcare Private Limited
Surajpur Site V, Greater Noida, Uttar Pradesh
SEND SMS
SEND EMAIL
Product Details:
| Usage | Hospital, Clinical |
| Packaging Size | 5 Dose (2.5 ml in each) |
| Lactose | 20 mg |
| Sorbitol | 10 mg |
| L Hystidin | 1.2 mg |
| L Alanin | 0.7 mg |
| Dose | 0.5 ml |
Product Details:
| Packaging Type | Vial |
| Brand | Bio Med |
| Usage | Hospital |
| Form | Liquid |
| Grade | Medicinal |
| Gender | Unisex |
Additional Information:
Product Details:
| Packaging Type | Box |
| Usage | Hospital, Clinical |
| Dose | One Dose |
| Type | Bio Typh Typhoid Vaccine |
Product Details:
| Minimum Order Quantity | 1000 Vial |
| Packaging Type | Box |
| Brand | Quadrimeningo |
| Dosage | Single Dose / Ten Dose |
| Storage Temperature | 2 to 8 degree C |
(Meningococcal Polysaccharide Vaccine)
(Group A, C, Y & W135)
Meningitis or Meningococcemia is caused by Neisseria meningitidis (Groups A, C, Y, W135) bacteria. It may be severe and life threatening. A variety of neurological and immunological complications are generally associated with the primary disease.
DESCRIPTION :
QUADRI MENINGO™ is to be used to protect against cerebrospinal meningitis caused by Neisseria meningitidis (Group A, C, Y & W 135). Quadri Meningo™ conforms to the I.P.
Product Details:
| Packaging Type | Vial |
| Usage | Clinical, Hospital |
| Storage | 2 Degree to 8 Degree C |
| Form | Liquid |
Product Details:
| Packaging Type | Vial |
| Dose/Strength (ex. 1 mg or 1 ml) | 10 ml |
| Usage | Clinical, Hospital |
| Form | Liquid |
Product Details:
| Packaging Type | Vial |
| Brand | Biopox |
| Usage | Hospital, Clinical |
| Form | Liquid |
Product Details:
| Packaging Type | Vial |
| Usage | Clinical |
| Brand | Bio Med |
| Form | Liquid |
| Insertion | By Injection |
| Grade | Medicinal |
We are the leading supplier of IPV, Inactivated Polio Vaccine. made available to our clients at competitive prices.
Additional Information:
Product Details:
| Usage | Clinical |
| Packaging Type | Vial |
| Brand | Biovencer |
| Form | Liquid |
| Grade | Medicinal |
| Gender | Unisex |
We are the leading supplier of Pentavalent Vaccine, WHO Prequalified. made available to our clients at competitive prices.
Additional Information:
Product Details:
| Minimum Order Quantity | 100 Vial |
| Packaging Type | Vial |
| Product Type | API |
| Usage | Clinical |
| Gender | Unisex |
| Grade | Medicinal |
| Form | Liquid |
We are the leading supplier of RABIES HUMAN MONOCLONAL ANTIBODY made available to our clients at competitive prices.
Additional Information:
Product Details:
| Usage | Protection against tuberculosis (TB) infection |
| Dose Form | Injection |
| Recommand Dose | 0.05 ml |
Product Details:
| Minimum Order Quantity | 1000 Unit |
| Packaging Type | Plastic Tube |
| accine strain | Quantity |
|---|---|
| V. cholerae O1 Inaba Cairo 48 (H) | 300 L.E.U* |
| V. cholerae O1 Inaba Phil 6973 El Tor (F) | 600 L.E.U |
| V. cholerae O1 Ogawa Cairo 50 (F) | 300 L.E.U |
| V. cholerae O1 Ogawa Cairo 50(H) | 300 L.E.U |
| V. cholerae O139 4260B (F) | 600 L.E.U |
Additional Information:
Product Details:
| Injectable Form | Lyophilized Powder |
For active immunization against Measles Administered to children and adolescents who have been vaccinated before or have had measles infection earlier
ROUTE OF ADMINISTRATIONSubcutaneous injection
DOSEIn Developing countries : At 9 months of Age
In industrialized countries: At 12 -15 months of Age
Additional Information:
Product Details:
| Packaging Type | Vial |
| Brand | Indirab |
| Dose/Strength (ex. 1 mg or 1 ml) | 0.5 |
| Usage | Clinical, Hospital |
Product Details:
| Packaging Type | Tube |
| Usage | Clinical, Hospital |
| Packaging Size | 20 Dose |
| Dose | 2 Drops |
Meningococcal Polysaccharide Vaccine)
(Group A, C, Y & W135)
Meningitis or Meningococcemia is caused by Neisseria meningitidis (Groups A, C, Y, W135) bacteria. It may be severe and life threatening. A variety of neurological and immunological complications are generally associated with the primary disease.
DESCRIPTION :
QUADRI MENINGO™ is to be used to protect against cerebrospinal meningitis caused by Neisseria meningitidis (Group A, C, Y & W 135). Quadri Meningo™ conforms to the I.P.
Rotavirus Vaccine (Live Attenuated, Oral) is a monovalent liquid frozen vaccine containing live rotavirus 116E strain [G9 P(11)] prepared in Vero cells for the prevention of rotavirus gastroenteritis. Each dose of 0.5 mL contains NLT 105.0 FFU of live Rotavirus 116E.
ROTAVAC® should be administered as a 3-dose regimen, 4 weeks apart, beginning at 6 weeks of age and should not be administered to children older than 8 months of age. ROTAVAC® has a shelf life of 5 years when stored at -20°C till the expiry date and can be stored for up to six months between 5°C ±3°C.
Additional Information: